Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by KayakerBCon Aug 02, 2017 2:48pm
203 Views
Post# 26539513

RE:RE:RE:RE:RE:financials

RE:RE:RE:RE:RE:financialsOK, so I've been away for a few days.  I missed all the dopey stuff Jekyl posted....

....lovincoal, that's not a clarification that's a restatement in order for you to try and deflect from your accusations.
i'm not going to let that go. it's not as easy as you think to throw around slanderous and defamatory insults, accusations and allegations and then trying to cover it up, and a feeble attempt at that....


Jekyl, weren't you a lawyer in a previous life?  Got any laws or case law you can sight to show that someone can be defamed when they are posting anonymously?

....for now the 67 cent bid and 62 cent 52 week low is something that can't be denied. oh and by the way, spare me the great buying opportunity speech....

Maybe it's a buying opportunity.

jd, nice banter but worthless and evidence that you missed the point of my post.
burn, that's all i'm looking at.... the burn.
you've got upcoming costs for the engineering of proteins for the nhp studies and less than $3M in the bank with a bleek $0.65 bid.


Jekyl, you whined and complained for the longest time about the lack of internal programs to move things forward.  Now you're complaining they will cost money.  LOL.

i keep telling myself that i'm not coming back here and yet i do.

Uh no, you keep telling us you're not coming back here and yet you do.

But Jekyl, don't worry, it looks like you've got it all figured out.  You predicted....

1. a Q2 2016 buyout,
2. a market cap of 10s of billions by now,
3. a stock price going nowhere by the end of 2017.  

I'm pretty sure that covers all possible outcomes, so I'm sure you'll be right.  At least you'll claim so.
Bullboard Posts